# The Economic Value of African Altruism

In health economics, does the cost differential for clinical trial participation create an economic value transfer from African communities to Northern pharmaceutical companies? This economic analysis estimated per-participant costs across regions using ClinicalTrials.gov enrollment data for 23,873 African trials and published industry benchmarks. Investigators reported the cost-per-participant ratio as the primary estimand for economic value extraction. Estimated per-participant costs of approximately 2,000 dollars in Africa compared to 41,000 dollars in the United States represent a ninety-five percent discount that drives the global migration of clinical trials to low-income settings. African communities provide participants, disease burden, and rapid enrollment — Africa's 2,313 currently recruiting trials demonstrate high recruitment throughput — while resulting drugs are priced for Western markets at costs exceeding African per-capita health expenditure. The economic value of African research altruism is estimated to exceed one billion dollars annually in cost savings to global pharmaceutical companies. These findings quantify the economic extraction pipeline as a measurable value transfer. Interpretation is limited by cost estimation from industry benchmarks rather than direct trial accounting.

## References

1. Petryna A. When Experiments Travel: Clinical Trials and the Global Search for Human Subjects. Princeton University Press; 2009.
2. Drain PK, et al. "Global migration of clinical trials." Nat Rev Drug Discov. 2018;17:765-766.

## Note Block

- Type: research
- App: https://mahmood726-cyber.github.io/africa-e156-students/governance-justice/dashboards/value-transfer.html
- Code: https://github.com/mahmood726-cyber/africa-e156-students/blob/master/governance-justice/code/value-transfer.py
- Data: ClinicalTrials.gov API v2
- Date: 2026-04-05